Eledon Pharmaceuticals In...
(ELDN)
undefined
undefined%
At close: undefined
4.44
0.91%
After-hours Dec 13, 2024, 05:32 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Net Income | -116.54M | -87.97M | -34.51M | -22.81M | -16.01M | -14.06M | -13.12M | -37.96M | -45.09M | -23.30M | -15.72M | -9.65M |
Depreciation & Amortization | 374.00K | 373.00K | 195.00K | 183.00K | 182.00K | 11.00K | 22.00K | 171.00K | 109.00K | 21.00K | 10.00K | 9.00K |
Stock-Based Compensation | 6.54M | 8.15M | 7.90M | 3.17M | 1.31M | 1.54M | 579.00K | 3.00M | 2.90M | 2.11M | 238.00K | 210.00K |
Other Working Capital | -2.32M | 287.00K | -2.29M | -141.00K | 189.00K | -476.00K | -517.00K | -1.31M | 561.00K | -556.00K | 760.00K | 216.00K |
Other Non-Cash Items | 75.01M | 48.65M | 6.15M | 4.83M | 1.87M | 471.00K | 49.00K | -2.00K | -235.00K | -158.00K | 238.00K | 210.00K |
Deferred Income Tax | - | - | -2.35M | -404.00K | - | - | - | 352.00K | 72.00K | - | -238.00K | -210.00K |
Change in Working Capital | -4.92M | 2.37M | -152.00K | -180.00K | -1.20M | 618.00K | -2.48M | -2.08M | 1.00M | 204.00K | 1K | 97.00K |
Operating Cash Flow | -39.53M | -28.42M | -28.91M | -15.21M | -13.86M | -11.89M | -14.94M | -36.52M | -41.24M | -21.12M | -15.48M | -9.33M |
Capital Expenditures | - | - | - | - | - | - | - | -17.00K | -565.00K | -25.00K | -23.00K | -8.00K |
Acquisitions | - | - | - | 11.04M | - | - | 23.25M | -2.00K | - | - | - | - |
Purchase of Investments | -78.29M | - | - | - | - | - | - | -500.00K | -39.88M | - | - | - |
Sales Maturities Of Investments | 33.00M | - | - | - | - | - | - | 36.20M | - | - | - | - |
Other Investing Acitivies | - | - | - | 11.04M | - | - | 8.00K | 2.00K | -70.00K | -150.00K | -30.00K | - |
Investing Cash Flow | -45.29M | - | - | 11.04M | - | - | 23.26M | 35.68M | -40.51M | -175.00K | -53.00K | -8.00K |
Debt Repayment | - | - | - | - | - | - | - | 2.93M | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - |
Dividend Paid | - | - | - | -25.00K | - | - | - | - | - | - | - | - |
Other Financial Acitivies | - | - | -449.00K | 100.58M | - | 71.00K | 3.12M | - | 513.00K | -3.13M | 35.59M | 18.78M |
Financial Cash Flow | 33.02M | - | -449.00K | 109.58M | 9.68M | 7.56M | 7.87M | 37.00K | 513.00K | 94.80M | 35.59M | 18.78M |
Net Cash Flow | -51.80M | -28.42M | -29.36M | 105.40M | -4.18M | -4.33M | 16.19M | -800.00K | -81.23M | 73.50M | 20.06M | 9.44M |
Free Cash Flow | -39.53M | -28.42M | -28.91M | -15.21M | -13.86M | -11.89M | -14.94M | -36.54M | -41.80M | -21.15M | -15.50M | -9.34M |